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1. Introduction 
Mannosidosis is a lysosomal storage disease of 
humans [ 1,2] and Angus cattle, [3,4 ] resulting from 
a deficiency of lysosomal acidic cu-D-mannosidase 
(EC 3.2.1.24). It has been suggested on the basis of 
its altered stability and kinetic properties that a 
mutant enzyme, resulting from a mutation in a struc- 
tural gene, accounts for the residual acidic a-D-man- 
nosidase in human [5-71 and bovine [8] mannosi- 
dosis. The mutant enzyme in bovine mannosidosis 
crossreacts with antiserum raised against normal 
bovine acidic a-D-mannosidase and accounts for all 
the crossreacting material present in bovine mannosi- 
dosis [9]. Antiserum raised against pig kidney acidic 
cu-D-mannosidase crossreacts with the acidic a-D- 
mannosidase in normal human fibroblasts and in other 
human and bovine tissues [lo]. Crossreacting material 
has also been detected by radio-immunological tech- 
niques in fibroblasts from two patients with mannosi- 
dosis using this antiserum [I 11. However, we present 
evidence in this paper that the mutant enzyme in 
another patient with mannosidosis does not crossreact 
with antiserum raised against normal human liver 
acidic a-D-mannosidase. Further no enzymically inac- 
tive crossreacting material was detected. 
2. Materials and methods 
2.1. Tissues 
Post-mortem human liver was stored at -20°C 
until required. Skin tibroblasts from a patient with 
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mannosidosis (case 1 reference 12) were kindly sup- 
plied by Dr A. D. Patrick (Institute of Child Health, 
London). Control fibroblasts were obtained by skin 
punch biopsy from normal donors. Fibroblasts were 
grown in 25 cm2 Falcon flasks containing basal 
medium (Eagle) dissolved in Earle’s balanced salt 
solution (Flow Laboratories Ltd, Irvine, Scotland) 
with addition of NaHCOa (2.2 g/l), glutamine (2 mM) 
and foetal calf serum (15% v/v) (Gibco-Biocult, Paisley, 
Scotland). The flasks were incubated at 37°C in 
COz:air (5 :95, v/v) atmosphere. Cells were harvested 
using a solution of trypsin (0.1%. w/v) (Wellcome 
Laboratories Ltd, Beckenham) in Hanks balanced salt 
solution (Flow). After 3 washes with phosphate buf- 
fered saline (Flow) and centrifugation, the cells were 
sonicated for two 15 s pulses at 20 kHz in an MSE 
Ultrasonic disintegrator. The supernatant after further 
centrifugation was used. Cells were counted using a 
haemocytometer. 
2.2. cY-D-mannosidase assay 
a-D-mannosidase was assayed using the fluorigenic 
substrate 4-methylumbelliferyl cy-D-mannopyranoside 
(Koch-Light Laboratories Ltd, Colnbrook, Bucks) as in 
[2] except that the substrate concentration was 
increased to 5 mM in the reaction mixture. One unit 
of activity is the amount of activity that transforms 
1 pmol substrate/min under these conditions. 
2.3. Preparation of acidic a-D-mannosidases A and B 
a-D-mannosidases A and B were prepared from 
normal human liver and fibroblasts by ion-exchange 
chromatography on DEAE-cellulose (Whatman DE-52) 
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[2]. Neutral a-D-mannosidase was removed from the 
liver extract by chromatography on concanavalin 
A-Sepharose (Pharmacia (GB) Ltd, London) prior to 
ion-exchange chromatography [ 131. 
2.4. Serological experiments 
Antiserum was raised in a rabbit against partially 
purified (0.3 U/mg protein) human liver acidic cu-D- 
mannosidase [ 13,141. Rabbit acidic a-D-mannosidase 
was removed from the antiserum by chromatography 
on concanavalin A-Sepharose. The glycosidases 
bound to the column whereas the immunoglobulin 
fraction was unretarded. Immunodiffusion and immu- 
noprecipitation experiments were carried out as in 
[ 141. Protein was determined by the Folin method 
[ 151 using bovine serum albumin as the standard. 
3. Results 
3.1. Immunoprecipitation of the O-D-mannosidase in 
normal human fibroblasts and in fibroblasts of a 
patient with mannosidosis 
The antiserum raised against the human liver acidic 
a-D-mannosidase precipitated all the acidic a-D-man- 
nosidase from an extract of a normal human liver 
(fig.1). This indicated that both the major forms of 
acidic a-D-mannosidase, A and B, separable by chro- 
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Fig.1. Immunoprecipitation of or-D-mannosidase in liver and 
tibroblasts. The enzyme preparation (50 ~1) and antiserum 
(l-10 ~1) were mixed and made up to final vol. 150 ~1 with 
phosphate-buffered saline, pH 7.4. The supernatants obtained 
after centrifugation of the mixtures were assayed for or-D- 
mannosidase at pH 4.0. (o) Liver (0.7 mu); (0) normal fibro- 
blasts (0.155 mu); (0) mannosidosis fibroblasts (0.041 mU); 
(m) normal fibroblasts assayed at pH 5.5 (0.169 mu). 
matography on DEAE-cellulose were precipitated. 
The neutral ol-D-mannosidase present did not cross- 
react. The majority of the acidic a-D-mannosidase in 
normal fibroblasts was also precipitated by the anti- 
serum but it was never possible to precipitate all the 
activity. The proportion of acidic activity remaining 
in solution varied from 1 O-40%. To investigate 
whether the intermediate or neutral a-D-mannosidases 
present in fibroblasts crossreacted with the antiserum, 
the ol-D-mannosidase activity was also assayed at 
pH 5.5. The immunoprecipitation curve shows that 
-50% activity at this pH is precipitated. However the 
acidic ol-D-mannosidase precipitated by the antiserum 
has appreciable activity at pH 5.5 and this would 
account for the activity at this pH precipitated by the 
antiserum. It is concluded that the intermediate or 
neutral a-D-mannosidases do not crossreact with the 
antiserum. 
The residual acidic a-D-mannosidase in the tibro- 
blasts of a patient with mannosidosis was also not 
precipitated by the antiserum. This showed either 
that the mutant enzyme did not crossreact with the 
antiserum or that its avidity for the antibodies was 
very much lower than that of the normal enzyme. 
Immunoprecipitation was also carried out with mix- 
tures of various proportions of material from normal 
and mannosidosis fibroblasts. The presence of material 
from fibroblasts of the patient with mannosidosis did 
not alter the concentration of antiserum required to 
precipitate the normal acidic a-D-mannosidase. This 
suggests either that enzymically inactive crossreacting 
material is absent in mannosidosis or that it is present 
in low concentrations and/or has a low avidity for the 
antibodies. 
3.2. Immunodiffusion 
When fibroblast acidic a-D-mannosidase A and B, 
prepared by chromatography on DEAE-cellulose, 
were placed in adjacent wells a continuous active 
immunoprecipitin band was observed (fig.2a). There 
was no evidence of spur formation. As both forms 
react with the antiserum, it is unlikely that a specific 
form of acidic a-D-mannosidase accounts for the 
activity that was not precipitated in the immunopre- 
cipitation experiments. The active precipitin line was 
also continuous with those obtained for a whole fibro- 
blast extract, a liver extract and a-D-mannosidase A 
and B prepared from liver Therefore the acidic a-D- 
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Fig.2. Immunodiffusion of liver and fibroblast acidic a-D-mannosidase against anti (a-D-mannosidase)-serum (AS). The immuno- 
precipitin lines were detected enzymically and the photographs are reproduced negatively. (a) 1, normal liver; 2, 3, liver acidic 
a-D-mannosidase A and B, respectively;4, normal fibroblasts; 5, 6, normal fibroblast acidic n-D-mannosidase A and B, respectively. 
(b) 1,4, 6 normal human liver; 2, mannosidosis fibroblasts; 3, normal fibroblasts; 5, normal bovine liver. 
mannosidase in normal human fibroblasts is immu- 
nologically identical to that in liver. 
No enzymically active precipitin line was observed 
with an extract of the fibroblasts from the patient 
with mannosidosis. Further no enzymically inactive 
crossreacting material was detected when the immu- 
nodiffusion plate was post-stained for protein. Protein 
bands corresponding to the enzymic activity were 
detected in normal liver and fibroblasts. Another 
crossreacting component not coincident with the 
enzyme was observed in human liver. It has been 
detected in human liver with this antiserum and is 
probably co-purified with the enzyme [ 13,141. Either 
it does not occur in fibroblasts or its concentration is 
too low for detection. The antiserum did not cross- 
react with normal bovine liver acidic a-D-mannosidase. 
4. Discussion 
The lack of crossreaction between the antiserum 
raised against the normal enzyme and the mutant 
enzyme in the fibroblasts from a patient with manno- 
188 
sidosis suggests that the mutation affects the antigenic 
sites as well as the stability and kinetic properties of 
cr-D-mannosidase. In addition no enzymically inactive 
crossreacting material was detected by immunoprecip- 
itation or immunodiffusion. In contrast evidence has 
been found by a radio-immunological technique, for 
the occurrence in fibroblasts from another patient 
with mannosidosis of material that crossreacts with 
anti-(pig acidic o-D-mannosidase) serum [9,10]. This 
antiserum has a wide specificity [lo], crossreacting 
with the normal bovine and human enzymes, whereas 
the anti-(human a-D-mannosidase) serum does not 
crossreact with the bovine enzyme. Therefore it is 
possible that the difference in specificity or avidity of 
the antisera might explain this apparent discrepancy. 
However, if the crossreacting material was present in 
mannosidosis-fibroblasts in comparable amounts with 
comparable avidity to those of the normal enzyme in 
normal cells, as has been suggested [I I], it should 
have been detected with our antiserum. An alternative 
explanation is that there are variants of mannosidosis. 
The residual acidic a-D-mannosidase in the fibroblasts 
of the patient with mannosidosis was thermolabile 
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but the Km value was only 1.3 mM compared with 
0.8-0.9 mM for controls (L.J.B., B.G.W., unpublished 
results). A 25fold increase in the Km value has been 
reported for the mutant enzyme in other cases of 
mannosidosis [6,16]. However the Km value for the 
activity in one of the patients in which crossreacting 
material was detected was not significantly different 
from that of the control [ 171. It has been claimed in 
other cases that the residual a-D-mannosidase is acti- 
vated 6-lo-fold by Zn2’ [ 181 or that the value of 
Km is decreased by Co’+ [7]. In our case the mutant 
enzyme is only activated by 20% by Zn2+ over a wide 
range of concentration and is inhibited by Co*+ 
(unpublished results). Therefore it is possible that 
there are variant forms of mannosidosis, which can be 
distinguished biochemically by differences in the 
kinetic properties and possibly immunological proper- 
ties of the mutant enzyme. 
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